Comparison DiaMedica Therapeutics (DMAC) with Competitors
DiaMedica Therapeutics (DMAC) industry is Biotechnology.
Free Cash Flow Yield
DMAC-7.54%
Industry-1.75%
Upside-5.79%
P/E
DMAC-11.02
Industry-20.52
Upside+949.69%
P/S
DMAC66.68
Industry10.01
Upside+565.90%
P/B
DMAC8.48
Industry5.15
Upside+64.76%